HESG Health Sciences Group Inc (CE)

Health Sciences Group, Inc. (OTCBB:HESG), provider of innovative health and wellness products, announced that it plans to expand the broadcast schedule of its 30-minute television infomercial for Sequesterol(TM) nutritional supplement. "The results from the Sequesterol infomercial test airing are encouraging," said Health Sciences Group's Chief Financial Officer Fred E. Tannous. "Call volume and conversion rates were in line with our expectations and present an opportunity for improvement. The next step in the process is to make the necessary edits to the infomercial based on statistical data generated from the test broadcasts, and then proceed to purchase air time for future airings in strategically selected markets." "When we produce an infomercial, we never know what the response will be until we test it," commented Jarrod Bentley, Campaign Manager of Take 2 Direct. "Based on the test results we've seen from the Sequesterol infomercial, we have identified a few areas that we can edit and are confident that when we finish the testing process we will have a successful campaign. This is a normal process in our business -- we look forward to helping make Sequesterol a successful product." Sequesterol includes vital nutrients which support cardiovascular health and help maintain a free-flowing circulatory system(a). This proprietary formulation is based on a unique combination of clinically-studied ingredients known to maintain healthy cholesterol levels, reduce the formation of plaque and protect against heart attack(a). For a limited time, Sequesterol is being offered at $14.95 for a 30-Day Risk-Free Trial, as seen in the television infomercial. For more information, please visit www.Sequesterol.com. (a) Statements relating to the health effects of Sequesterol have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. About Health Sciences Group Health Sciences Group is dedicated to developing and acquiring unique and innovative products that support and enhance a "healthstyle" with a focus on nutrition, wellness and functional well-being. For more information, please visit www.HealthSciencesGroup.com and www.Sequesterol.com. This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although the Company believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including without limitation, the independent authority of the special committee to act on the matters discussed, the successful negotiation of the potential acquisition and disposal of transactions described above, successful implementation of the company's business strategy and competition, any of which may cause actual results to differ materially from those described in the statements. In addition, other factors that could cause actual results to differ materially are discussed in the Company's most recent Form 10-QSB and Form 10-KSB filings with the Securities and Exchange Commission.